Medical Device | January 06, 2022
Thermo Fisher Scientific acquires PeproTech for US $1.85 bn
PeproTech's recombinant proteins portfolio complements Thermo Fisher's cell culture media products
PeproTech's recombinant proteins portfolio complements Thermo Fisher's cell culture media products
Biogen paid Ionis a US $ 60 million one-time upfront payment
The test kit is compatible with all standard Real-Time PCR machines with a test run time of 85 minutes. The result turnaround time, including sample collection and RNA extraction, is 130 minutes
Upon completion of successful human trials and regulatory approval, the joint venture's goal is to start delivering the second-generation vaccine in 2022 as soon as is practically possible
Partnering to build biosynthesis processes and a pharmaceutical production platform
ASC10 is an oral direct-acting antiviral drug candidate targeting RNA dependent RNA polymerase (RdRp) to treat SARS-CoV-2 infection
All the recommendations have been sent to the Drugs Controller General of India (DCGI) for final approval.
Molnupiravir is an orally administered form of a potent ribonucleoside analog that inhibits the replication of SARS-CoV-2
SK bioscience secures long-term license to supply the Novavax vaccine for the Korean market
Sucharita brings with her a rich and varied experience of two decades in Information Technology and Financial Services
Subscribe To Our Newsletter & Stay Updated
